Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Miryana Radosevich"'
Autor:
Jerard Seghatchian, Mohamed Elemary, Hadi Goubran, Thierry Burnouf, Magdy El-Ekiaby, Miryana Radosevich
Publikováno v:
Cancer Growth and Metastasis
Cancer Growth and Metastasis, Vol 2016, Iss 9, Pp 1-8 (2016)
Cancer Growth and Metastasis, Vol 9 (2016)
Cancer Growth and Metastasis, Vol 2016, Iss 9, Pp 1-8 (2016)
Cancer Growth and Metastasis, Vol 9 (2016)
For many years, transfusion of allogeneic red blood cells, platelet concentrates, and plasma units has been part of the standard therapeutic arsenal used along the surgical and nonsurgical treatment of patients with malignancies. Although the benefit
Autor:
Thierry Burnouf, Miryana Radosevich
Publikováno v:
Vox Sanguinis. 98:12-28
Intravenous immunoglobulin G (IVIG) is now the leading product obtained by fractionation of human plasma. It is the standard replacement therapy in primary and acquired humoral deficiency, and is also used for immunomodulatory therapy in various auto
Publikováno v:
Analytical Biochemistry. 389:69-73
The capacity of hydrophobic octadecyl (C18) and SDR HyperD materials to remove the combination of 1% (v/v) solvent (tri-n-butyl phosphate, TnBP) with 1% (v/v) nonionic detergents (Triton X-100 and Triton X-45) used for viral inactivation of plasma-de
Publikováno v:
ISBT Science Series. 4:99-106
Background Availability of safe and affordable human plasma-derived products (factor VIII, prothrombin complex concentrate/FIX, albumin and intravenous immunoglobulin) is a main concern of healthcare providers, particularly in resource-limited countr
Publikováno v:
ISBT Science Series. 4:136-142
Blood-derived biomaterials include fibrin sealant (FS) (also called fibrin glue), platelet gel (PG), and platelet fibrin glue. They are used in many surgical fields because of their functional properties and unique physical advantages compared to syn
Publikováno v:
Transfusion Clinique et Biologique. 15:129-134
Resume Le plasma pour transfusion, le cryoprecipite et le surnageant de cryoprecipite prepares par les etablissements de transfusion sanguine sont toujours utilises dans de nombreux pays, a la fois dans le monde en developpement comme dans celui indu
Publikováno v:
ISBT Science Series. 2:121-128
Non-virally inactivated cryoprecipitate prepared by blood banks is still used in many countries, especially in the developing world, for the treatment of bleeding disorders due to factor VIII (FVIII), von Willebrand factor (VWF), or fibrinogen defici
Autor:
Thierry Burnouf, Miryana Radosevich
Publikováno v:
Current Pharmaceutical Analysis. 3:83-94
Publikováno v:
Journal of Chromatography B. 790:199-207
Protein C deficiency (inherited and acquired) has a relatively high incidence rate in the general population worldwide. For many years, protein C deficient patients have been treated with fresh frozen plasma, prothrombin complex concentrates, heparin
Autor:
Sherif N Amin, Geoffrey F. Savidge, Miryana Radosevich, Magdy El-Ekiaby, S. Satoh, Hadi Goubran, T. Sato, Thierry Burnouf
Publikováno v:
Vox Sanguinis. 84:111-119
BACKGROUND AND OBJECTIVES Major technical developments have been made in recent years to improve the quality and safety of human plasma for transfusion and fractionation. The present study was performed to assess, for the first time, the feasibility